Joel Schlessinger M.D.
Published works by Joel Schlessinger M.D.
February, 2015
The FDA approved a new treatment for plaque psoriasis after Joel Schlessinger MD’s participation in a successful clinical study
The Food and Drug Administration recently approved COSENTYX® (secukinumab) for the treatment of moderate to severe plaque psoriasis. Joel Schlessinger MD and his staff at the Advanced Skin Research Center participated in a successful clinical study with this drug. Their participation was vital in the approval of COSENTYX®. The study conducted by Joel Schlessinger MD […]
Posted in Published Works | No Comments »